Spotlight -

Concierge Medicine Forum|

News|Videos|June 28, 2024

PAI: Introducing the Physicians Advocacy Institute

Author(s)Richard Payerchin

CEO discusses consolidation in health care.

In June 2024, the Physicians Advocacy Institute sent a letter outlining concerns about effects of consolidation in health care to three federal agencies reviewing current market conditions: The U.S. Departments of Justice, Health and Human Services, and the Federal Trade Commission. CEO Kelly Kenney, JD, introduces the Physicians Advocacy Institute with some history about the organization.

Newsletter

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Related Content

AI-designed drug lowered patients' predicted biological age; chatbots abandon referral advice when patients push back; virtual reality helped anxious patients finish cardiac scans - Morning Medical Update © kwanchaichaiudom - stock.adobe.com

AI-designed drug could slow aging; chatbots abandon referral advice when patients push back; virtual reality helped anxious patients finish cardiac scans — Morning Medical Update

ByAustin Littrell

September 9th 2026

Jinwoo Hong: ©Delta Branding

Why adding more marketing tactics won't prove a physician's expertise

September 8th 2026

How to optimize physicians' largest controllable expense: tax planning

ByBill Martin, CFA

September 8th 2026

Man charged with laundering proceeds of $1.3B Medicare fraud; GLP-1 prescribing is climbing among grade schoolers; a dementia clue in the voice - Morning Medical Update © meeboonstudio - stock.adobe.com

Man charged with laundering proceeds of $1.3B Medicare fraud; GLP-1 prescribing is climbing among grade schoolers; a dementia clue in the voice — Morning Medical Update

ByAustin Littrell

September 8th 2026

girl with too much media © shintartanya - stock.adobe.com

Where misinformation about patient health actually comes from

ByRichard Payerchin

September 7th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Medical Economics

Man charged with laundering proceeds of $1.3B Medicare fraud; GLP-1 prescribing is climbing among grade schoolers; a dementia clue in the voice — Morning Medical Update

Patients trust fake physician reviews more than real ones, study finds

Nearly 3 in 4 health plans lost money in 2025 — and the gap between winners and losers is widening

Where misinformation about patient health actually comes from

AI scribes fail to note patient experiences, U.K. review finds